EFNAs

EFNAs, short for ephrin-A ligands, refer to a family of GPI-anchored membrane proteins that serve as ligands for the Eph family of receptor tyrosine kinases (Eph receptors). In humans the EFNA gene family includes EFNA1, EFNA2, EFNA3, EFNA4 and EFNA5. The proteins are GPI-anchored, lack cytoplasmic domains, and are tethered to the outer surface of the plasma membrane, enabling them to engage Eph receptors on adjacent cells during cell-cell contact.

EFNAs bind preferentially to EphA receptors, mediating contact-dependent signaling that influences cell adhesion, shape, and movement. Forward signaling occurs in the Eph receptor-expressing cell, while reverse signaling can occur in the EFNA-expressing cell through indirect mechanisms, including interactions with co-receptors or proteolytic processing, though reverse signaling is less canonical for ephrin-A ligands due to their lack of intracellular domains.

Functions attributed to EFNAs include roles in development and tissue organization. They contribute to axon guidance and the formation of orderly neural connections, as well as vascular patterning and angiogenesis. In the adult, ephrin-A signaling participates in synaptic organization and remodeling and helps regulate cellular interactions at tissue interfaces.

Regulation of EFNA expression is developmentally controlled and tissue-specific. Transcriptional and environmental cues influence levels of EFNAs, and proteolytic processing can release soluble forms that modulate signaling dynamics. The precise balance of EFNA and Eph receptor activity shapes cell positioning and connectivity in multiple organ systems.

Clinical and research interest in EFNAs centers on their involvement in cancer progression, tumor angiogenesis, neural development, and tissue repair. EFNAs are investigated as potential targets to modulate Eph-ephrin signaling in disease and regeneration contexts.